<code id='0E842A7C7D'></code><style id='0E842A7C7D'></style>
    • <acronym id='0E842A7C7D'></acronym>
      <center id='0E842A7C7D'><center id='0E842A7C7D'><tfoot id='0E842A7C7D'></tfoot></center><abbr id='0E842A7C7D'><dir id='0E842A7C7D'><tfoot id='0E842A7C7D'></tfoot><noframes id='0E842A7C7D'>

    • <optgroup id='0E842A7C7D'><strike id='0E842A7C7D'><sup id='0E842A7C7D'></sup></strike><code id='0E842A7C7D'></code></optgroup>
        1. <b id='0E842A7C7D'><label id='0E842A7C7D'><select id='0E842A7C7D'><dt id='0E842A7C7D'><span id='0E842A7C7D'></span></dt></select></label></b><u id='0E842A7C7D'></u>
          <i id='0E842A7C7D'><strike id='0E842A7C7D'><tt id='0E842A7C7D'><pre id='0E842A7C7D'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:comprehensive    Page View:5216
          George Yancopoulos on the 2024 Breakthrough Summit East stage.
          George Yancopoulos on the 2024 Breakthrough Summit East stage STAT

          George Yancopoulos is in touch with his teenage self.

          After 35 years as head scientist at Regeneron Pharmaceuticals, Yancopoulos has led the development of 12 approved medicines, turning a once-fledgling company into the $100 billion global drugmaker it is today. And you can trace a straight line back to the childhood fascination with science he fostered growing up in Woodside, Queens.

          advertisement

          “My high school science project was about regenerating neurons, and ‘Regeneron’ is a contraction of ‘regenerating neurons,’” Yancopoulos said at the STAT Summit East on Thursday. “In some ways I’m still working on my high school science project.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more
          3 trends to watch in health tech's hiring outlook for 2024
          3 trends to watch in health tech's hiring outlook for 2024

          ChristineKao/STATHealthtechhopefulsmightoncehavebeenusedtoawealthofjoboptions,especiallyinthepandemi

          read more
          Virginia high school admissions case could be legal follow
          Virginia high school admissions case could be legal follow

          3:24DemonstratorsprotestoutsideoftheSupremeCourtinWashington,Thursday,June29,2023,aftertheSupremeCou

          read more

          Ahead of JPM, here's who's profiting most in health care

          AdobeForalltheflaktheyget,thecountry’sfourbiggestpharmacybenefitmanagersreportedasurprisinglytameave